Israel has been held up as the “gold standard” of how to conduct the coronavirus vaccine rollout. It has seen approximately 70% of its population receive the jab. The Israelis have relied in the main on the Pfizer vaccine. However, recently the country’s Prime Minister, Naftali Bennett, stated that the Pfizer vaccine is ‘significantly less’ effective against the so-called Delta variant. This follows on from a statement last June by Ran Balicer, who leads an expert advisory panel for the Israeli government, in announcing that the country might end up in lockdown again.
Already a subscriber? Log in
Get 10 issues
for $20
Subscribe to The Spectator Australia today for the next 10 magazine issues, plus full online access, for just $20.
- Delivery of the weekly magazine
- Unlimited access to spectator.com.au and app
- Spectator podcasts and newsletters
- Full access to spectator.co.uk
Or
Comments
Don't miss out
Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.
SUBSCRIBEAlready a subscriber? Log in